Table 5.
Disease specific survival (DSS) by tumor entity
| Primary tumor site | Mean survival (months) |
1 month (%) |
6 months (%) |
12 months (%) | 24 months (%) | 36 months (%) |
|---|---|---|---|---|---|---|
| Breast carcinoma (n = 31) | 26.3 | 95.5 | 77.3 | 72.7 | 40.9 | 22.7 |
| Renal cell carcinoma (n = 15) | 18.1 | 90.0 | 45.5 | 9.1 | 0 | 0 |
| Urothelial Carcinoma (n = 3) | 1.3 | 50.0 | 0 | 0 | 0 | 0 |
| Prostate carcinoma (n = 27) | 25.4 | 83.3 | 66.7 | 41.7 | 16.7 | 8.3 |
| NSCLC (n = 25) | 11.7 | 62.5 | 33.3 | 16.7 | 12.5 | 4.2 |
| SCLC (n = 2) | 1.0 | 100 | 0 | 0 | 0 | 0 |
| CUP adenocarcinoma (n = 6) | 6.2 | 50.0 | 50 | 0 | 0 | 0 |
| Esophageal carcinoma (n = 3) | 4.7 | 33.3 | 33.3 | 0 | 0 | 0 |
| Colon carcinoma (n = 1) | 1.0 | 100 | 0 | 0 | 0 | 0 |
| Rectal carcinoma (n = 3) | 7.7 | 66.7 | 33.3 | 33.3 | 0 | 0 |
| Thyroid carcinoma (n = 1) | 50.0 | 100 | 100 | 100 | 100 | 100 |
| Laryngeal carcinoma (n = 1) | 1.0 | 100 | 0 | 0 | 0 | 0 |
| Rhabdomyosarcoma (n = 2) | 9.5 | 50.0 | 50.0 | 50.0 | 0 | 0 |
| Leiomyosarcoma (n = 1) | 44.0 | 100 | 100 | 100 | 100 | 100 |
| Angiosarcoma (n = 2) | 5.5 | 50.0 | 0 | 0 | 0 | 0 |
| Multiple myeloma (n = 15) | 20.7 | 90.0 | 80.0 | 70.0 | 30.0 | 10.0 |
| B-cell lymphoma (n = 2) | 42.0 | 100 | 50 | 50 | 50 | 50 |
| Chronic lymphocytic leukemia (n = 1) | 34.0 | AWD | - | - | - | - |
| Malignant melanoma (n = 1) | 20.0 | AWD | - | - | - | - |
| Penile carcinoma (n = 1) | 3.0 | 100 | 0 | 0 | 0 | 0 |
| Hepatocellular carcinoma (n = 1) | 0.0 | 0 | 0 | 0 | 0 | 0 |
| Gastrointestinal stromal tumor (n = 1) | 1.0 | 100 | 0 | 0 | 0 | 0 |
Abbreviations AWD = alive with disease